Indegene

Indegene Limited is a technology-native life sciences commercialization company that operates at the intersection of life sciences and technology. The company covers the full value chain from commercialization strategy through execution, serving clients across clinical, medical, and commercial functions. Founded over 25 years ago, Indegene integrates domain knowledge, contextualized technology, and operational delivery to help life sciences organizations bring therapies to market and engage patients and healthcare professionals more effectively.

Indegene serves biopharmaceutical companies, emerging biotech firms, and medical device manufacturers. All 20 of the world's top 20 biopharma companies are listed among its clients. The company employs more than 5,000 team members across 17 offices worldwide and delivers services through consulting, Centers of Excellence, Functional Capability Centers, and development and co-commercialization models.

Who Indegene Serves

• Biopharmaceuticals: Large and established biopharma organizations seeking to improve commercial operations, medical affairs, and clinical execution.
• Emerging Biotech: Smaller and growth-stage biotech companies looking to commercialize therapies efficiently.
• Medical Devices: Device manufacturers requiring digital and commercial support across their go-to-market activities.

Core Solution Areas

• Enterprise Commercial Solutions: Focuses on improving the effectiveness and efficiency of commercial operations, elevating customer experience, and accelerating transformation for life sciences companies.
• Enterprise Medical Solutions: Supports regulatory compliance, market access expansion, medical affairs experience, and pharmacovigilance productivity.
• Enterprise Clinical Solutions: Covers patient recruitment for clinical trials, trial operations management, and utilization of Real-World Data and Real-World Evidence (RWD/RWE).
• Technology Solutions: Delivers scalable, secure, and intelligent technology implementations designed to accelerate digital transformation and drive enterprise-wide efficiency across life sciences organizations.
• Omnichannel Activation Solutions: Supports revenue growth, customer experience enhancement, and team augmentation through a modern go-to-market model for healthcare professional engagement.
• Generative AI-Powered Commercialization: Applies generative AI with deep industry context to accelerate commercial impact and build trust across life sciences use cases.

Technology Platforms and Products

• Cortex: An enterprise-grade platform for adopting and scaling generative AI across commercialization use cases, with built-in governance controls.
• Connected Commercial: An integrated ecosystem designed to transform commercial operations by accelerating decision-making, enhancing engagement, and driving efficiency at scale.
• Connected Content Ecosystem: A generative AI and platform-driven approach to unifying the content value chain in life sciences and elevating customer experience.
• Agency of Scale: A model that evolves and scales Agency of Record (AOR) concepts more efficiently through a fractional access approach.
• NEXT Technology Platforms: Contemporary, life sciences-specific technology platforms designed to scale outcomes in a non-linear way and with speed.

Delivery Models

• Consulting: Strategic advisory services supporting commercialization planning and execution.
• Centers of Excellence: Specialized delivery hubs focused on specific functional or therapeutic areas.
• Functional Capability Centers: Operational units providing dedicated functional expertise to client organizations.
• Development and Co-Commercialization: Collaborative models where Indegene participates directly in the development and commercialization of therapies alongside clients.

Recent Developments and Partnerships

• Indegene acquired BioPharm Communications to expand its AI-led marketing capabilities, adding expertise in omnichannel strategy, end-to-end media journey planning, data-driven campaign execution, analytics, automation, and precision marketing.
• The company has developed capabilities around Agentforce, enabling modular, compliant, always-on AI agents powered by governed automation, high-quality data, and a scalable intelligence layer for life sciences enterprise transformation.
• Indegene partners with leading technology organizations to integrate and contextualize modern technology platforms for life sciences-specific applications.

Recognition and Certifications

• CMMI Level 5 Certified and rated Platinum 2025 by Cybervadis for cybersecurity practices.
• Recognized as a Leader in Everest Group's PEAK Matrix Assessment 2025 for Life Sciences AI and Analytics Services for Commercial.
• Named a Leader in Everest Group's Life Sciences Digital Services Specialists PEAK Matrix Assessment 2024 and Life Sciences Sales and Marketing Operations PEAK Matrix Assessment 2023.
• Identified as a Market Leader in the HFS Horizons Life Sciences Service Providers 2023 report and a Leader in ISG's Provider Lens for Life Sciences Digital Services.
• Recognized as a Front-runner in Operationalizing Generative AI in Life Sciences by Everest Group.
• Received multiple Stevie Awards across healthcare technology and artificial intelligence categories in 2024 and 2025.
• Winner of the Deloitte Technology Fast 50 India award in HealthTech in both 2023 and 2024.
• Received EcoVadis Silver Medal ESG assessments in 2024 and 2025, and a Bronze Medal in 2023.
• Recognized by Great Place to Work India and listed among India's Top 50 Best Workplaces in Health and Wellness.
• Received the BIG Innovation Award 2025 and the AI Breakthrough 2024 Data Warehouse Solution of the Year award.
• Ranked as a top firm for Data Scientists by Analytics India Magazine and named Data Engineering Company of the Year 2024.

Indegene positions itself as a specialist that combines 25 years of life sciences domain experience with technology and operational delivery capabilities, serving the full spectrum of life sciences organizations from large biopharma to emerging biotech and medical device companies across clinical, medical, and commercial functions.